共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R023421-100mg | 100mg | 5~7个工作日 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
98% |
|
|
罗恩 | R023421-25mg | 25mg | 5~7个工作日 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
98% |
|
|
阿拉丁 | W124987-5mg | 5mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
阿拉丁 | W124987-25mg | 25mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
阿拉丁 | W124987-100mg | 100mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
凯为 | JZ001UF2-5mg | 5mg | 期货,请咨询 |
N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-... Cyclohexanecarboxamide, N-[2... |
99% |
|
|
凯为 | JZ001UF2-10mg | 10mg | 期货,请咨询 |
N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-... Cyclohexanecarboxamide, N-[2... |
99% |
|
|
凯为 | JZ001UF2-25mg | 25mg | 期货,请咨询 |
N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-... Cyclohexanecarboxamide, N-[2... |
99% |
|
|
凯为 | JZ001UF2-50mg | 50mg | 期货,请咨询 |
N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-... Cyclohexanecarboxamide, N-[2... |
99% |
|
|
凯为 | JZ001UF2-100mg | 100mg | 期货,请咨询 |
N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-... Cyclohexanecarboxamide, N-[2... |
99% |
|
|
毕得 | BD424436-10mg | 10mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
毕得 | BD424436-50mg | 50mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
毕得 | BD424436-100mg | 100mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
毕得 | BD424436-25mg | 25mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
毕得 | BD424436-5mg | 5mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
毕得 | BD424436-250mg | 250mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
安耐吉 | M0139573-100mg | 100mg | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
安耐吉 | M0139573-1g | 1g | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
安耐吉 | M0139573-2.5g | 2.5g | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
安耐吉 | M0139573-250mg | 250mg | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
安耐吉 | M0139573-500mg | 500mg | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
安耐吉 | M0139573-50mg | 50mg | 期货,请咨询 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
源叶 | Y27848-5mg | 5mg | 期货,请咨询 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
源叶 | Y27848-25mg | 25mg | 期货,请咨询 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
源叶 | Y27848-100mg | 100mg | 期货,请咨询 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
Target Mol | T21561-100mg | 100mg | 期货,请咨询 |
化合物 WAY-100635 WAY-100635 |
|
|
|
Target Mol | T21561-5mg | 5mg | 期货,请咨询 |
化合物 WAY-100635 WAY-100635 |
|
|
|
Target Mol | T21561-2mg | 2mg | 期货,请咨询 |
化合物 WAY-100635 WAY-100635 |
|
|
|
Am | A138712-25mg | 25mg | 现货 |
WAY-100635 WAY-100635 |
98% |
|
|
Am | A138712-50mg | 50mg | 现货 |
WAY-100635 WAY-100635 |
98% |
|
|
Am | A138712-5mg | 5mg | 现货 |
WAY-100635 WAY-100635 |
98% |
|
|
Am | A138712-10mg | 10mg | 现货 |
WAY-100635 WAY-100635 |
98% |
|
|
Am | A138712-100mg | 100mg | 现货 |
WAY-100635 WAY-100635 |
98% |
|
|
MCE | HY-10349-100mg | 100mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
MCE | HY-10349-50mg | 50mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
MCE | HY-10349-10mg | 10mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
MCE | HY-10349-5mg | 5mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|